BANK VONTOBEL/CALL/PFIZER INC/34/0.1/20.09.24 Share Price

Warrant

DE000VM3RDN3

Delayed Deutsche Boerse AG 18:55:12 25/06/2024 BST
0.008 EUR +14.29% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/34/0.1/20.09.24
1 month-65.22%
3 months-74.19%
Date Price Change
25/06/24 0.008 +14.29%
24/06/24 0.007 -12.50%
21/06/24 0.008 -11.11%
20/06/24 0.009 +12.50%
19/06/24 0.008 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 06:55 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM3RDN
ISINDE000VM3RDN3
Date issued 09/10/2023
Strike 34 $
Maturity 20/09/2024 (87 Days)
Parity 10 : 1
Emission price 0.29
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.007
Delta0.09x
Omega 16.66
Premium21.99x
Gearing193.87x
Moneyness 0.8232
Difference Strike 6.01 $
Difference Strike %+17.68%
Spread 0.013
Spread %65.00%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99 USD
Average target price
31.92 USD
Spread / Average Target
+14.02%
Consensus